Glaucoma eye drops: systemic beta-blocker effects, punctal occlusion and drop spacing

The main drop classes and what they do

Glaucoma damages the optic nerve, often painlessly, and lowering intraocular pressure slows that damage. Drop classes include prostaglandin analogues such as latanoprost, beta blockers such as timolol, alpha-adrenergic agonists, carbonic anhydrase inhibitors, miotics, and newer rho kinase inhibitors. Many patients use more than one, which creates the technique and spacing problems tested on exams.

Local effects are common across classes: stinging, burning, itching, redness and blurred vision. Some patients notice headache, dry mouth or changes in energy or heart rate. Because the drops do not make the eye feel or see better, motivation to keep using them is low, so adherence teaching is part of the medication plan rather than an extra.

Beta-blocker drops act on the whole body

Eye drops drain through the tear duct into the nose, where they are absorbed into the bloodstream. Timolol labelling warns that this systemic absorption can produce the same effects as an oral beta blocker. It is contraindicated in bronchial asthma, severe chronic obstructive pulmonary disease, sinus bradycardia, second or third degree heart block, overt heart failure and cardiogenic shock.

The nurse checks respiratory and cardiac history before a beta-blocker drop is started, takes a baseline pulse and reports bradycardia, dizziness, wheeze or breathlessness. The label also warns that it can mask signs of hypoglycaemia in diabetes, may worsen weakness in myasthenia gravis, and adds to the effects of oral beta blockers, so the full medication list matters.

Prostaglandin drops and visible changes

Latanoprost increases fluid outflow from the eye and is usually used once daily. Its label warns that it can darken the iris, eyelid skin and eyelashes, and that iris colour change is likely to be permanent, developing over months to years. Eyelashes may grow longer, thicker and darker, though these lash changes usually reverse when the drug stops.

Patients using a drop in only one eye should know the eyes may end up looking different. The label also describes macular oedema and intraocular inflammation in susceptible people, so new blurred or distorted vision, pain or marked redness is reported. Contact lenses are removed before instillation and reinserted after 15 minutes because the preservative can be absorbed.

Technique: punctal occlusion and spacing drops

After instilling a drop, the patient closes the eye and presses lightly on the inner corner, over the tear duct, for at least one minute. This punctal occlusion keeps more drug in the eye and reduces the amount reaching the bloodstream, which particularly matters for beta-blocker drops. The bottle tip should not touch the eye, lids or fingers, to prevent contamination and infection.

When more than one type of drop is prescribed, the patient waits at least five minutes between them so the first is not washed out; some product labels suggest longer, so follow the specific instructions. Ask for a return demonstration, check the patient can manage the bottle and see the schedule, and plan for missed doses rather than doubling up.

Working a hypothetical eye-drop scenario

Picture an imagined older adult with heart failure and glaucoma who has just been prescribed timolol drops. At the next visit the pulse is 48 and the patient reports dizziness and tiring easily. The options are to tell the patient eye drops cannot cause this, reinforce punctal occlusion only, hold the drop and notify the prescriber, or add a second drop to reduce the timolol dose.

Holding and notifying the prescriber is the best response because systemic beta blockade is a likely cause and overt heart failure is a labelled contraindication. Telling the patient drops are harmless is wrong, punctal occlusion helps but does not replace review, and adding a drug is outside the nurse's role. This is a study scenario.

Sources and further reading

DailyMed: Timoptic-XE (timolol maleate) prescribing information. Systemic absorption, contraindications in asthma, COPD, bradycardia, heart block and heart failure, hypoglycaemia masking, myasthenia and oral beta-blocker interactions.

DailyMed: Xalatan (latanoprost) prescribing information. Permanent iris pigmentation, eyelash changes, macular oedema, contact lens timing, five-minute spacing and tip contamination.

National Eye Institute: How to put in eye drops. Closing the eye and pressing the tear duct for at least one minute, waiting five minutes between drop types, avoiding tip contact.